Back to search
PKP2 Arrhythmogenic Cardiomyopathy (PKP2-ACM)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which PKP2 Arrhythmogenic Cardiomyopathy (PKP2-ACM) trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which PKP2 Arrhythmogenic Cardiomyopathy (PKP2-ACM) trials you may qualify forThis Phase 1 dose escalation trial will assess the safety and preliminary efficacy of a single dose intravenous infusion of RP-A601 in high-risk adult patients…
The goal of this study is to describe the natural history and clinical events for patients who have Arrhythmogenic Cardiomyopathy with Pathogenic Plakophilin-2…
An observational study to assess real-world patient characteristics and clinical course of disease in participants with PKP2-ACM.
This first-in-human study is designed to evaluate the safety, and preliminary efficacy (PD) of TN-401 gene therapy in adult patients with symptomatic PKP2 mutat…
This is a multicenter, non-interventional study to observe the natural progression of the disease and to study the prevalence of pre-existing antibodies to AAV9…
The goal of this clinical trial is to test IC14 (atibuclimab) in patients with arrhythmogenic cardiomyopathy (ACM) and who have an implantable cardoverter/defib…
The primary objective of this Phase 1/2 long-term follow-up (LTFU) study is to assess the long-term safety and tolerability of LX2020 for the treatment of arrhy…
This is a Phase 1/2, first-in-human, open-label, intravenous, dose-escalating, multicenter trial that is designed to assess the safety and tolerability of LX202…